Taiwo Oladapo

Array ( [id] => 15311625 [patent_doc_number] => 10520512 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-31 [patent_title] => Method for predicting the risk of a subject for contracting diabetes mellitus and/or metabolic syndrome or for diagnosing metabolic syndrome in a subject [patent_app_type] => utility [patent_app_number] => 14/383422 [patent_app_country] => US [patent_app_date] => 2013-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 5507 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14383422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9812464 [patent_doc_number] => 20150024409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'METHODS AND SYSTEMS FOR PREDICTING DRUG-RESPONSE' [patent_app_type] => utility [patent_app_number] => 14/380064 [patent_app_country] => US [patent_app_date] => 2013-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9927 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14380064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9280770 [patent_doc_number] => 20140030738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-30 [patent_title] => 'SOLUBLE HUMAN M-CSF RECEPTOR AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/771395 [patent_app_country] => US [patent_app_date] => 2013-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 9902 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13771395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9930896 [patent_doc_number] => 20150079089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-19 [patent_title] => 'EMP2 REGULATES ANGIOGENESIS IN CANCER CELLS THROUGH INDUCTION OF VEGF' [patent_app_type] => utility [patent_app_number] => 14/376724 [patent_app_country] => US [patent_app_date] => 2013-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 23705 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14376724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8927482 [patent_doc_number] => 20130183242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-18 [patent_title] => 'METHODS FOR IDENTIFYING TUMOR-SPECIFIC POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/744953 [patent_app_country] => US [patent_app_date] => 2013-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11754 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13744953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9798970 [patent_doc_number] => 20150010914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-08 [patent_title] => 'BIOMARKERS FOR GASTRIC CANCER AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/373332 [patent_app_country] => US [patent_app_date] => 2013-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20807 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14373332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9930901 [patent_doc_number] => 20150079093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-19 [patent_title] => 'DUAL ANTIGEN-INDUCED BIPARTITE FUNCTIONAL COMPLEMENTATION' [patent_app_type] => utility [patent_app_number] => 14/371910 [patent_app_country] => US [patent_app_date] => 2013-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 42819 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14371910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10445970 [patent_doc_number] => 20150330985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-19 [patent_title] => 'GALECTIN-7 AS A BIOMARKER FOR DIAGNOSIS, PROGNOSIS AND MONITORING OF OVARIAN AND RECTAL CANCER' [patent_app_type] => utility [patent_app_number] => 14/654195 [patent_app_country] => US [patent_app_date] => 2012-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13758 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14654195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8755951 [patent_doc_number] => 20130090256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'BIOMARKERS FOR EARLY DETECTION OF OVARIAN CANCER' [patent_app_type] => utility [patent_app_number] => 13/688077 [patent_app_country] => US [patent_app_date] => 2012-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 24475 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13688077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8915923 [patent_doc_number] => 20130177548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-11 [patent_title] => 'TREATING NEOPLASMS WITH NEUROTOXIN' [patent_app_type] => utility [patent_app_number] => 13/685490 [patent_app_country] => US [patent_app_date] => 2012-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22191 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13685490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10968062 [patent_doc_number] => 20140371095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-18 [patent_title] => 'NOVEL METHOD FOR IDENTIFYING SPECIFIC MARKER SEQUENCES FOR PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 14/357806 [patent_app_country] => US [patent_app_date] => 2012-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12833 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14357806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8814200 [patent_doc_number] => 20130115245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'Vaccine for Tumor Immunotherapy' [patent_app_type] => utility [patent_app_number] => 13/665145 [patent_app_country] => US [patent_app_date] => 2012-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5991 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13665145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8814200 [patent_doc_number] => 20130115245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'Vaccine for Tumor Immunotherapy' [patent_app_type] => utility [patent_app_number] => 13/665145 [patent_app_country] => US [patent_app_date] => 2012-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5991 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13665145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9685832 [patent_doc_number] => 20140242597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'PREDICTING TUMOR RESPONSE TO ANTI-ERBB3 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/349916 [patent_app_country] => US [patent_app_date] => 2012-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 10625 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9799650 [patent_doc_number] => 20150011594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-08 [patent_title] => 'BIN1 EXPRESSION AS A MARKER OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/348269 [patent_app_country] => US [patent_app_date] => 2012-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14205 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14348269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8722984 [patent_doc_number] => 20130074201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'CANCER-SPECIFIC GENETIC REARRANGEMENTS' [patent_app_type] => utility [patent_app_number] => 13/621460 [patent_app_country] => US [patent_app_date] => 2012-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 22998 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13621460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9003060 [patent_doc_number] => 20130224185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'PROTEIN FORMULATION' [patent_app_type] => utility [patent_app_number] => 13/619576 [patent_app_country] => US [patent_app_date] => 2012-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17487 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13619576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10905250 [patent_doc_number] => 20140308263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-16 [patent_title] => 'ENDOSTATIN MUTANTS WITH MUTATIONS AT ATP BINDING SITES' [patent_app_type] => utility [patent_app_number] => 14/343694 [patent_app_country] => US [patent_app_date] => 2012-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 10779 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10905250 [patent_doc_number] => 20140308263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-16 [patent_title] => 'ENDOSTATIN MUTANTS WITH MUTATIONS AT ATP BINDING SITES' [patent_app_type] => utility [patent_app_number] => 14/343694 [patent_app_country] => US [patent_app_date] => 2012-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 10779 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10421185 [patent_doc_number] => 20150306196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-29 [patent_title] => 'POLYPEPTIDE VACCINE' [patent_app_type] => utility [patent_app_number] => 14/342644 [patent_app_country] => US [patent_app_date] => 2012-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 41398 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14342644 [rel_patent_id] =>[rel_patent_doc_number] =>)